In Europe, the iPax Eyepax, an online statistic education system that was commercialized using the Yokohama Trial Grant, and the Speech Speech Speech Speech Center, which was commercialized using LIP. Yokohama Trial Grant

Yokohama City is promoting the "Yokohama Life Innovation Platform" (LIP. Yokohama), a network of industry, academia and government that continuously creates innovation in the health and medical fields.
The developer Telemedica Co., Ltd. (Aoba Ward) obtained a European patent and U.S. patent, following a domestic patent and U.S. patents were developed using the LIP. Yokohama Trial Grant (FY2018 and FY2019). As a result, the expansion of sales channels is expected to accelerate expansion in sales channels in Japan and the United States as well as European patent member countries.
Yokohama City will continue to collaborate with overseas offices to support the overseas expansion of local companies in the city.